Zelluna is a Norwegian biotechnology company developing T-cell receptor (TCR)-based natural killer (NK) cell therapies for cancer, with a focus on treating solid tumors. Its…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see ZELLUNA →Already a subscriber? Sign in
Xcout Intel tracks ZELLUNA continuously — this profile deepens as new filings, funding, people and hiring data arrive.